Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion

Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion

US Patent 10760076 · Granted Sep 1, 2020

Estimated economic value: $5,232,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chemically modified single-stranded rna-editing oligonucleotides2025
Antisense oligonucleotides for the treatment of Stargardt disease2024
Single-stranded RNA-editing oligonucleotides2024
Nucleic acid molecules for pseudouridylation2024
Chemically modified single-stranded RNA-editing oligonucleotides2023
Targeted RNA editing2023
Single-stranded RNA-editing oligonucleotides2023
Antisense oligonucleotides for the treatment of eye disease2022
Oligonucleotide complexes for use in RNA editing2022
Oligonucleotides to treat eye disease2021
Antisense oligonucleotides to treat dystrophic epidermolysis bullosa2021
Single-stranded RNA-editing oligonucleotides2021